<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FE0E616-6A75-4DCC-BA07-3ADF018A9669"><gtr:id>9FE0E616-6A75-4DCC-BA07-3ADF018A9669</gtr:id><gtr:name>National Cancer Research Institute</gtr:name><gtr:address><gtr:line1>National Cancer Research Institute</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Cancer Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FE0E616-6A75-4DCC-BA07-3ADF018A9669"><gtr:id>9FE0E616-6A75-4DCC-BA07-3ADF018A9669</gtr:id><gtr:name>National Cancer Research Institute</gtr:name><gtr:address><gtr:line1>National Cancer Research Institute</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/16C512BE-2E4C-4170-BFC3-1CC5186B0AC3"><gtr:id>16C512BE-2E4C-4170-BFC3-1CC5186B0AC3</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Gray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A47BB0A4-29B1-46AB-A0A8-0F7497EE8E5D"><gtr:id>A47BB0A4-29B1-46AB-A0A8-0F7497EE8E5D</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Wheatley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CA9E922B-25AF-4E91-AE02-E77663EDF6EA"><gtr:id>CA9E922B-25AF-4E91-AE02-E77663EDF6EA</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Lilford</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/08692C1D-B5DD-44E8-BE33-3A65CDE3A504"><gtr:id>08692C1D-B5DD-44E8-BE33-3A65CDE3A504</gtr:id><gtr:firstName>Melanie</gtr:firstName><gtr:surname>Calvert</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FC534787-BCBD-478D-AF8A-6E2A71421C4A"><gtr:id>FC534787-BCBD-478D-AF8A-6E2A71421C4A</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B76908A8-587E-4D54-808B-890F5D6CAD08"><gtr:id>B76908A8-587E-4D54-808B-890F5D6CAD08</gtr:id><gtr:firstName>Sue</gtr:firstName><gtr:surname>Wilson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2C0EDC2F-3E48-4DC7-911D-5565EF88CAD5"><gtr:id>2C0EDC2F-3E48-4DC7-911D-5565EF88CAD5</gtr:id><gtr:firstName>Frederick</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Hobbs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3D1510C3-2D29-486D-8344-B4D494CC9169"><gtr:id>3D1510C3-2D29-486D-8344-B4D494CC9169</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:surname>Freemantle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DED83FBA-0427-4F66-9BAD-7348361E1C81"><gtr:id>DED83FBA-0427-4F66-9BAD-7348361E1C81</gtr:id><gtr:firstName>Lucinda</gtr:firstName><gtr:surname>Billingham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/90D4423B-912E-4222-BCC7-D0C91A9D1A66"><gtr:id>90D4423B-912E-4222-BCC7-D0C91A9D1A66</gtr:id><gtr:firstName>Stirling</gtr:firstName><gtr:surname>Bryan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/77468A17-A0DD-40CE-B11B-8D1FB21E1C5D"><gtr:id>77468A17-A0DD-40CE-B11B-8D1FB21E1C5D</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Zeegers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5F475A93-A5C1-4161-9CDD-EB4E099C142C"><gtr:id>5F475A93-A5C1-4161-9CDD-EB4E099C142C</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Deeks</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/41190D9E-F548-4705-A8F9-CC1882BBBD03"><gtr:id>41190D9E-F548-4705-A8F9-CC1882BBBD03</gtr:id><gtr:firstName>Brendan</gtr:firstName><gtr:surname>Delaney</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800808"><gtr:id>07A39698-66EF-4446-A465-DC5A361E4AF7</gtr:id><gtr:title>Midland Hub for Trials Methodology Research at University of Birmingham</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800808</gtr:grantReference><gtr:abstractText>Clinical trials test potential treatments in humans to see if they should be approved for wider use in the general population. Any new treatment must be extensively tested to check that it benefits patients, is safe and doesn t have unacceptable side effects. Most often the treatment is a drug, but it could be a medical device, a surgical or physical procedure, a therapy or an intervention such as health promotion. Volunteers are recruited into the clinical trial to undergo the new treatment and usually the trial will include a group who just receive the standard treatment. In this way, the outcome of patients on the new treatment can be compared to the standard to see if it is beneficial. Planning how the trial will be run and making sure it addresses the right questions are important to ensure that the results from the trial will be useful. Interpreting the data that is collected in the trial also needs to guarantee that valid conclusions are reached. The plan for this research is to create a regional facility at the University of Birmingham in which to investigate the best ways to design, conduct and analyse trials, providing advice, support and training to those carrying out trials and to the public. Ultimately this will result in beneficial treatments being delivered to patients more efficiently.</gtr:abstractText><gtr:technicalSummary>The aim of the Midland Hub at University of Birmingham is to be a centre of excellence for trials methodology research, providing local and national researchers undertaking trials with innovative methodology for design, conduct and analysis, thereby improving the quality of trials. The Hub will develop existing expertise in trials methodology at Birmingham to deliver a high-quality Research Programme that will be of practical use to the trials community. There is a culture of collaborative working at Birmingham and the Hub will continue to cultivate regional, national and international collaborations to facilitate the successful delivery of research. A comprehensive training programme in trials methodology will train the potential experts of the future and educate trial practitioners in methodology. By providing a mechanism for advice, support and dissemination the Hub will benefit the trials community and ultimately patient care.
Our proposed research programme centres around the current specialist methodological areas but the wealth of expertise will enable us to develop new research themes identified as important by the clinical trials community. There are seven key research themes at Birmingham: (1) Quality of life evaluation for clinical and health economic assessment; (2) Discovery and evaluation of diagnostic, prognostic and predictive biomarkers; (3) Methods to obtain reliable conclusions and involve users; (4) Bayesian methods in design and analysis of trials; (5) E-trials; (6) Systematic review for clinical and health economic assessment; (7) Education in trial methodology. Methodological expertise within the Research Programme feeds into all major areas within the trial process i.e. pre-trial development, trial design and set-up, trial conduct, trial analysis and evidence synthesis.
In summary, Birmingham is at the heart of the trials community, providing academic expertise based on real-life trial experience, ready access to a wealth of datasets that can be used for methodology research, real situations in which to implement new methodology and direct support to many members of the clinical trial community. As one of the leading centres in the UK for clinical trials, the University of Birmingham is the ideal location for the Midland Hub for Trials Methodology Research.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2547692</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Epidemiology and Health Care</gtr:department><gtr:description>The PROGRESS initiative</gtr:description><gtr:id>2EE1A88B-90F9-4D5D-A272-BA1A40DDE277</gtr:id><gtr:impact>3 workshops that brought together 25 national and international experts (including journal editors, clinicians, statisticians, epidemiologists, and economists) across multiple disease fields to develop a framework for improving prognosis research. These workshops have led to a series of 4 articles that are being revised for the BMJ/PLoS Med, describing the four key aspects of prognosis research: overall prognosis, prognostic factors, prognostic models and predictive factors for stratified medicine. These articles serve as an introduction to the field of prognosis, and why it is important and the necessary steps toward improvement</gtr:impact><gtr:outcomeId>KMdJpWRpNyZ-1</gtr:outcomeId><gtr:partnerContribution>I am a co-lead of the PROGRESS initiative (PROGnosis RESearch Strategy) alongside Harry Hemmingway, UCL, and Doug Altman, Oxford. Since 2009 we have organised 3 workshops that brought together 25 national and international experts (including journal editors, clinicians, statisticians, epidemiologists, and economists) across multiple disease fields to develop a framework for improving prognosis research. These workshops have led to a series of 4 articles that are being revised for the BMJ/PLoS Med, describing the four key aspects of prognosis research: overall prognosis, prognostic factors, prognostic models and predictive factors for stratified medicine. These articles serve as an introduction to the field of prognosis, and why it is important and the necessary steps toward improvement.</gtr:partnerContribution><gtr:piContribution>Richard Riley co-lead of the PROGRESS initiative (PROGnosis RESearch Strategy) alongside Harry Hemmingway, UCL, and Doug Altman, Oxford. Since 2009 we have organised 3 workshops that brought together 25 national and international experts (including journal editors, clinicians, statisticians, epidemiologists, and economists) across multiple disease fields to develop a framework for improving prognosis research. These workshops have led to a series of 4 articles that are being revised for the BMJ/PLoS Med, describing the four key aspects of prognosis research: overall prognosis, prognostic factors, prognostic models and predictive factors for stratified medicine. These articles serve as an introduction to the field of prognosis, and why it is important and the necessary steps toward improvement.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Cancer Research Institute (NCRI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NCRI Clinical and Translational Radiotherapy Research Working Group</gtr:department><gtr:description>CTRad: Clinical Trials in Radiotherapy</gtr:description><gtr:id>BC156782-BD77-4FFC-BDB8-7819D18FEB15</gtr:id><gtr:impact>Methodology Workshop and papers in preparation</gtr:impact><gtr:outcomeId>EjqNpy54xTD-1</gtr:outcomeId><gtr:partnerContribution>Methodology Workshop and papers in preparation</gtr:partnerContribution><gtr:piContribution>Chair of Phase III Workstream</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Statistics</gtr:department><gtr:description>Cochrane Prognosis Methods Group</gtr:description><gtr:id>4F487D9B-F894-44F3-9309-9A6ED262E44D</gtr:id><gtr:impact>We continually provide advice to national and international researchers conducting systematic reviews of prognosis studies. The convenors also provide recommendations for how prognosis information should be included in Cochrane Reviews of interventions, and if and when the Collaboration should formally introduce reviews of prognosis studies</gtr:impact><gtr:outcomeId>g1xpFsXhb7z-1</gtr:outcomeId><gtr:partnerContribution>I am a co-convenor of the International Cochrane Prognosis Methods Group (initiated in 2006) alongside Jill Hayden (Canada), Doug Altman (UK), Karel Moons (The Netherlands), and Katrina Williams (Australia). We continually provide advice to national and international researchers conducting systematic reviews of prognosis studies. The convenors also provide recommendations for how prognosis information should be included in Cochrane Reviews of interventions, and if and when the Collaboration should formally introduce reviews of prognosis studies</gtr:partnerContribution><gtr:piContribution>Richard Riley is co-convenor of the International Cochrane Prognosis Methods Group (initiated in 2006) alongside Jill Hayden (Canada), Doug Altman (UK), Karel Moons (The Netherlands), and Katrina Williams (Australia).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC ConDuCT Trials Methodology Hub</gtr:department><gtr:description>Biologic therapies for rheumatoid and psoriatic arthritis: Consensus models for decision-making</gtr:description><gtr:id>D8774810-AC29-48EE-BDB8-8B336A33B8C6</gtr:id><gtr:impact>The immediate output will be the consensus statement which will set out the preferred model for decision-making in biologic therapies, as proposed by our independent group of clinicians, modelling experts, and regulators. We will also establish a collaborative modelling group through this process, and put together a grant application as described above. Finally, we will document the process through which consensus was achieved, along with insights for the successful development of preferred decision models in other disease areas</gtr:impact><gtr:outcomeId>nLazesNZi3G-1</gtr:outcomeId><gtr:piContribution>extensive expertise in HTA modelling, and developed the Birmingham Rheumatoid Arthritis Model, which has been used to inform a number of NICE technological appraisals</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Statistics</gtr:department><gtr:description>Reporting guidelines for Risk Prediction Models</gtr:description><gtr:id>E9FDE5E2-1B86-4D07-B5D4-ABD1CA4D0812</gtr:id><gtr:impact>The group has produced an initial set of guidelines, that are currently being refined.</gtr:impact><gtr:outcomeId>J5x9RZPKst4-1</gtr:outcomeId><gtr:partnerContribution>I am part of a collaboration (led by Gary Collins and Doug Altman, Oxford, and Karel Moons, Utrecht) developing reporting guidelines for prediction models. The group has produced an initial set of guidelines, that are currently being refined.</gtr:partnerContribution><gtr:piContribution>Richard Riley is part of a collaboration (led by Gary Collins and Doug Altman, Oxford, and Karel Moons, Utrecht) developing reporting guidelines for prediction models. The group has produced an initial set of guidelines, that are currently being refined.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>2nd Clinical Trial Methodology Conference, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>48D5737B-5F79-4435-9C52-1A279FB46082</gtr:id><gtr:impact>Using systematic reviews to identify research gaps -
a case study 131I-mIBG for the treatment
of neuroblastoma in children
Wilson, J et al

represented Midland hub for trials methodology research</gtr:impact><gtr:outcomeId>AnJE1doWndF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.methodologyconference2013.org.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Clinical Trials Methodology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A285BB0-1388-4C84-B326-A04BEBAE2CBE</gtr:id><gtr:impact>Challenges in the development of prognostic models
utilising clinical trials data
Kym IE Snell1, Lucinda J Billingham1,2, Deborah D Stocken3, Richard D Riley1
MRC Midland Hub for Trials Methodology Research, University of Birmingham, UK
2 Cancer Research UK Clinical Trials Unit, University of Birmingham, UK
3 Newcastle Clinical Trials Unit, Institute of Health and Society, Newcastle University, UK
Email: kxs105@bham.ac.uk

Represented Midland Hub for Trials Methodology Research</gtr:impact><gtr:outcomeId>ct67GtegbFn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.methodologyconference2013.org.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swedish Lung Cancer Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B7FF9731-23A9-4B59-BCDB-7FB13E40B973</gtr:id><gtr:impact>National meeting of Swedish thoracic Oncologists

influence decisions regarding strategy for biomarker trials in lung cancer</gtr:impact><gtr:outcomeId>CneqwHorMA1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Quality of Life Assessment in Cancer Research' workshop-Medical School, University of Birmingham-17.11.2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>6D9DDB03-4CDC-40C3-B7FA-16D40B1514C5</gtr:id><gtr:impact>Participants (approx 80) attended a workshop of presentations which evoked questions, debates and discussions

Request for further sessions</gtr:impact><gtr:outcomeId>KSTgKkXbicL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at NCRI Cancer Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>5C11A2B7-1394-4A10-AC84-B2BEB7CBCE75</gtr:id><gtr:impact>Poster presentation at NCRI Cancer Conference 'Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency Indications'

Knowledge for clinicians</gtr:impact><gtr:outcomeId>aMm2W5PQrNK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Quality of Life Assessment in Cancer Research' workshop-Medical School, University of Birmingham 17.02.2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>63225747-A7BD-42C2-826B-55F836811474</gtr:id><gtr:impact>Participants (approx 80) attended a workshop of presentations which evoked questions, debates and discussions

request for further sessions</gtr:impact><gtr:outcomeId>D6oD7isjQ1Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting on Stratified Medicine</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>2AD7A861-AE01-494A-A978-ADE7858CCEA2</gtr:id><gtr:impact>Workshop on stratified medicine

dissemination of knowledge on stratified medicine</gtr:impact><gtr:outcomeId>bMQuRvPfRMb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at NCRI Cancer Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>459FA262-600F-4443-B42F-87F4B7E7BA17</gtr:id><gtr:impact>Poster Presentation at NCRI Cancer Conference 'Quality-adjusted survival analysis using the integrated quality survival product: comparison of utilities and profile measures using a large phase III randomised clinical trial in lung cancer'

knowledge for clinicians</gtr:impact><gtr:outcomeId>acg26nMN6Vd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Nottingham Clinical Trials Unit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DF5D2B38-BBB0-4E9D-B978-7DEF7F24A98C</gtr:id><gtr:impact>Dissemination about trials methodology and Hub

Potential collaboration on future trial designs</gtr:impact><gtr:outcomeId>dthyb89aZSX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral Presentation at NCRI Cancer Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>15FECC53-7CBE-4602-945A-B872B844FAD0</gtr:id><gtr:impact>Speaker on 'Adaptive Trial Designs that Incorporate Biomarkers'

Provided knowledge for clinicians</gtr:impact><gtr:outcomeId>J3b5Eik8LPb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Clinical Trials Methodology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D874B8DD-7390-4827-B496-98ECFAA043E2</gtr:id><gtr:impact>Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design
Josephine N Khan1*, Christina Yap2, Richard Clark3, Nicola Fenwick1, David Marin4 1 Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK 2 MRC Midland Hub for Trials Methodology Research, University of Birmingham, Birmingham, UK 3 Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK 4 Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK

Represented Midland Hub for Trials Methodology Research</gtr:impact><gtr:outcomeId>SvBuo39oLtG</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.methodologyconference2013.org.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral Presentation at World Conference on Lung Cancer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FA1A9864-8B18-4859-98C9-5E05BDE17B24</gtr:id><gtr:impact>Speaker to an international audience of lung cancer clinicians on 'How to design a meta-analysis in biomarkers'

Provided knowledge for clinicians</gtr:impact><gtr:outcomeId>SF8g6F3YF43</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral Presentation at World Conference on Lung Cancer Young Investigators Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>860AE3B7-D2DE-40CA-B2B2-2642A8E839C6</gtr:id><gtr:impact>Speaker to international audience of young lung cancer clinicians on 'Trial Designs for Biomarker assessment'

Provided knowledge for clinicians</gtr:impact><gtr:outcomeId>JWViFCAeesP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Clinical Trials Methodology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FC49ECD0-C44A-4646-AF59-FFD296C531BC</gtr:id><gtr:impact>FLEXIBLE TRIAL DESIGN IN A RARE CONDITION
Veronica Moroz1, Keith Wheatley1, 2, Martin McCabe3
1 Cancer Research UK Clinical Trials Unit, University of Birmingham; 2 MRC Midland Hub for Trials Methodology Research, University of Birmingham;
3 Institute of Cancer Sciences , Manchester Academic Health Science Centre , University of Manchester.

Represented Midland Hub for Trials Methodology Research</gtr:impact><gtr:outcomeId>XX249wq2qe2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.methodologyconference2013.org.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Keele Clinical Trials Unit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B8C80523-4E91-4438-A7C1-38422E29EA50</gtr:id><gtr:impact>Dissemination about Trials Methodology and Hubs

Potential collaboration on future trial designs</gtr:impact><gtr:outcomeId>ZAahmS4qaiE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Taunton Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>264F976A-2E15-44A4-8007-E7F2AA351026</gtr:id><gtr:impact>20 clinicians attended and learnt about interpreting results from lung cancer trials

Improved knowledge of clinical community</gtr:impact><gtr:outcomeId>PhtnUNixLEn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Doctoral Fellowship</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5B0615C9-40C1-4F46-9AED-C4904CCEFF0B</gtr:id><gtr:outcomeId>NeBXn4iCc2y0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>96780</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Nova Scotia Health Research Foundation Establishment Grant Competition</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Nova Scotia Health Research Foundation</gtr:fundingOrg><gtr:id>BF666E7B-CFB2-4069-B789-411FD2C73504</gtr:id><gtr:outcomeId>rZDPx3yearU0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Commission Seventh Framework Programme (FP7)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>49D49710-E345-424F-93C1-D716B1E6192C</gtr:id><gtr:outcomeId>DAtc4do1nZC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61556</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Department of Health Research Support Facility funded PhD studentship</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A207FD51-9191-4B13-81FA-3983507AF94A</gtr:id><gtr:outcomeId>mFypgHJvaQK0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>980410</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Partnership Grant for (PROGRESS)</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DAC2B7BB-A726-4389-8873-DD3EB2EF4BD7</gtr:id><gtr:outcomeId>KyZsHi6Y2r60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Post Graduate overseas work experience placement scholarship College of Medicine and Denistry, University of Birmingham</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>263A59EC-1CE1-407C-9E90-7FF8B74B69EA</gtr:id><gtr:outcomeId>hsMi59Afv9t0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>241472</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA 10/44/01</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4E200002-2AA2-4EEB-B5DC-AB7B23B74B86</gtr:id><gtr:outcomeId>PNUbtAY3f3g0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Postdoctoral Research Fellowship</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>DEDFA6C3-B9ED-4672-82CE-F844E31C2700</gtr:id><gtr:outcomeId>MQu7sffRHLU0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>742492</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4E2C7E57-A490-4F51-B0AA-55E54B94AF0B</gtr:id><gtr:outcomeId>rTREL8yHz7r0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>69432</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Queen Elizabeth hospital Birmingham Charity</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Queen Elizabeth Hospital Birmingham Charity (QEHB)</gtr:fundingOrg><gtr:id>4683D1E1-AF3F-4BC1-9D66-B1979BFAA401</gtr:id><gtr:outcomeId>YRUGpFGetqY0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Commission Seventh Framework Programme (FP7)</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D7A7956D-EA95-48CC-B100-F03587A591EE</gtr:id><gtr:outcomeId>FTCVZUmHxbY0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1987326</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Grant</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>EF532FA9-616C-417F-9694-1511A574DB1B</gtr:id><gtr:outcomeId>ULwiUVNW7Gu0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85260</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>School for Primary Care Research</gtr:department><gtr:description>NIHR National School Primary Care Research</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D72C29B3-35BC-4DAA-830E-2B5686FDD570</gtr:id><gtr:outcomeId>qrqgcABJnuv0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49540</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0D408DE4-41F7-41A3-AA3D-C4D455E4A3F7</gtr:id><gtr:outcomeId>rBnBf8Gokby0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1621734</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA 09/22/117</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>950A7E30-6DEF-46CC-9B2D-A824AFA379E4</gtr:id><gtr:outcomeId>Wh4bVSCBFpy0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200529</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA 10/36/02</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7EE886F6-0B14-4F4A-AA0F-FFB6C338C346</gtr:id><gtr:outcomeId>Ko4KtMq3Knt0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Hub Network funding</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9F85BED4-B631-43A4-B27A-46BDBE1B1D12</gtr:id><gtr:outcomeId>EELFTsA5Qo60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research for Patient Benefit</gtr:department><gtr:description>NIHR RfPB</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>599BBF8C-5207-4286-B7EA-A4D843D2AB02</gtr:id><gtr:outcomeId>FbnPwn9HJmx0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Developed (with Hub member Ghada Abo-Zaid) a database of all IPD meta-analysis articles published up to March 2009</gtr:description><gtr:id>3698E854-253B-4664-8356-C0FA191378D4</gtr:id><gtr:impact>Empirical research regarding how IPD meta-analyses are undertaken, how IPD is collected, the biases involved, and the necessary reporting standards and guidelines for improvement</gtr:impact><gtr:outcomeId>MhhjXMCJ7Ky</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>a database of all IPD meta-analysis articles published up to March 2009</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Developed numerous techniques for performing and estimating multivariate (random effects) meta-analysis models which synthesis multiple correlated outcomes. See associated published papers</gtr:description><gtr:id>746753FF-CBFB-4B23-A13D-D46201462E10</gtr:id><gtr:impact>See associated published papers. Also, a workshop about how to perform multivariate meta-analysis at the RSS, and the methods have been implemented within the STATA module 'mvmeta'</gtr:impact><gtr:outcomeId>Zwu65CixwEV</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Developed numerous techniques for performing and estimating multivariate (random effects) meta-analysis models</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DF7D3A52-FBC6-45F0-9E46-120C9AD1745E</gtr:id><gtr:title>Multivariate meta-analysis: potential and promise.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>SyqZ5ZA6C6Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EB0994E-7998-43BE-A953-7178314EFC21</gtr:id><gtr:title>Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da228590f1d8180e3b5c35ebb96f8623"><gtr:id>da228590f1d8180e3b5c35ebb96f8623</gtr:id><gtr:otherNames>Yap C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>pm_16423_23_23819695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32E8E675-8091-4DBE-832D-4293051A2676</gtr:id><gtr:title>Association between long-term exposure to air pollution and specific causes of mortality in Scotland.</gtr:title><gtr:parentPublicationTitle>Occupational and environmental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da228590f1d8180e3b5c35ebb96f8623"><gtr:id>da228590f1d8180e3b5c35ebb96f8623</gtr:id><gtr:otherNames>Yap C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1351-0711</gtr:issn><gtr:outcomeId>kBc8X3Y4E2H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFC59243-C69D-45A9-B046-C1127BE32EFC</gtr:id><gtr:title>Comparison of anticipated and actual control group outcome in randomised trials in paediatric oncology provides evidence that non-randomised studies are biased in favour of the novel treatment</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/274181cdb38b6ce405ba8a1b2fd19c97"><gtr:id>274181cdb38b6ce405ba8a1b2fd19c97</gtr:id><gtr:otherNames>Moroz V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>kJvds6zUCNs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7781F0E-63A4-4C30-97CB-1EE5A844F5EE</gtr:id><gtr:title>Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8290b7f5b7c86818d2c3c3966a5f2268"><gtr:id>8290b7f5b7c86818d2c3c3966a5f2268</gtr:id><gtr:otherNames>Orlando R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>VHBBgWyTgYb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19363677-E52A-4973-A6F2-A046076E7C30</gtr:id><gtr:title>Comparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/274181cdb38b6ce405ba8a1b2fd19c97"><gtr:id>274181cdb38b6ce405ba8a1b2fd19c97</gtr:id><gtr:otherNames>Moroz V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>doi_55f984984c9d339e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89E0E81D-8CA2-466D-80F1-933CEE49FD0A</gtr:id><gtr:title>An investigation of the construct validity of the ICECAP-A capability measure.</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>NVFqo5wt5DX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>027803A6-49ED-4E0C-B63E-3A2E0D33E776</gtr:id><gtr:title>Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da3f80746934a474ab22d9e48967f00e"><gtr:id>da3f80746934a474ab22d9e48967f00e</gtr:id><gtr:otherNames>Hubner RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>dp7aLFcoUdG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9648BAAF-3EB4-4A32-A0DB-D7B2D718B559</gtr:id><gtr:title>Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>ftPR4ofvLmK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC860EF0-F866-4953-82E3-DA30203A4673</gtr:id><gtr:title>A systematic review investigating fatigue, psychological and cognitive impairment following TIA and minor stroke: protocol paper.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ca661304b63f777d416a6b8e069c55"><gtr:id>93ca661304b63f777d416a6b8e069c55</gtr:id><gtr:otherNames>Moran GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>hBLqFSQXLzd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CD7574B-E475-41E7-AA81-3E894A3B3CE1</gtr:id><gtr:title>Estimation of a preference-based carer experience scale.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>XTKwJxbkY2X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57913AE9-66DE-40B4-997C-692D840AD366</gtr:id><gtr:title>The impact of home-based physiotherapy interventions on breathlessness during activities of daily living in severe COPD: a systematic review.</gtr:title><gtr:parentPublicationTitle>Physiotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33e0690e7a6d1e6fdeab1f995f5a7e7e"><gtr:id>33e0690e7a6d1e6fdeab1f995f5a7e7e</gtr:id><gtr:otherNames>Thomas MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-9406</gtr:issn><gtr:outcomeId>mhSV6ZJxWDi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2930F32-E357-40B2-939A-7FD2304F0A5A</gtr:id><gtr:title>A systematic review of systematic reviews and panoramic meta-analysis: staples versus sutures for surgical procedures.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>cU6pyR8DnoL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7153B80C-DD32-45FC-AD2E-75F63E613BDA</gtr:id><gtr:title>Bivariate meta-analysis of predictive values of diagnostic tests can be an alternative to bivariate meta-analysis of sensitivity and specificity.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ff959e171f7ed993ec9069258464d1b"><gtr:id>8ff959e171f7ed993ec9069258464d1b</gtr:id><gtr:otherNames>Leeflang MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>tyETGoTPPvH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F1A793-A3B7-4125-82B6-AF73828BFD29</gtr:id><gtr:title>An empirical study on the preferred size of the participant information sheet in research.</gtr:title><gtr:parentPublicationTitle>Journal of medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbf3f8c89f7e0ec355f97cc6f221c428"><gtr:id>cbf3f8c89f7e0ec355f97cc6f221c428</gtr:id><gtr:otherNames>Antoniou EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0306-6800</gtr:issn><gtr:outcomeId>AjojfTgrYwp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DFD9E36-716A-4225-9C9E-F0109AD76E74</gtr:id><gtr:title>Cost-effective undergraduate medical education?</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bf6611591218096f0ac5f732e375725"><gtr:id>3bf6611591218096f0ac5f732e375725</gtr:id><gtr:otherNames>Calvert MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>L4835X44RLp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DFAF1A2-1605-4907-945A-F591006E6E2E</gtr:id><gtr:title>Ten steps towards improving prognosis research.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bb45c4c7a5bcec753842366297e3e48"><gtr:id>3bb45c4c7a5bcec753842366297e3e48</gtr:id><gtr:otherNames>Hemingway H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>XSRbXrd5yHy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5D6CEAB-A29E-4A74-859C-5470875B7189</gtr:id><gtr:title>Caesarean section surgical techniques: a randomised factorial trial (CAESAR).</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bded585dcf9c60e130e3e9143f15ac1"><gtr:id>4bded585dcf9c60e130e3e9143f15ac1</gtr:id><gtr:otherNames>CAESAR study collaborative group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>UkgyEhvqnZV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E20F511-F35F-421A-B7BF-6D4C114188B9</gtr:id><gtr:title>Clinical effectiveness in cardiovascular trials in relation to the importance to the patient of the end-points measured.</gtr:title><gtr:parentPublicationTitle>Journal of evaluation in clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71d7f40f94356d7678782b2f0f6136dc"><gtr:id>71d7f40f94356d7678782b2f0f6136dc</gtr:id><gtr:otherNames>Bowater RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1356-1294</gtr:issn><gtr:outcomeId>KyuLLFDxAvM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D288CA61-6057-4ED5-BE08-CC91062BD87C</gtr:id><gtr:title>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb9cf73d2b51a05787820a4496dc6cc0"><gtr:id>fb9cf73d2b51a05787820a4496dc6cc0</gtr:id><gtr:otherNames>Whiting PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>eEHTm1yPcY5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19FD23EB-B8EF-4A8B-993E-D90E8B1C6C48</gtr:id><gtr:title>The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6003a504a142016f62e8fe890b4b4e77"><gtr:id>6003a504a142016f62e8fe890b4b4e77</gtr:id><gtr:otherNames>Pourgheysari B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>qW3VrAAsnZ6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CFCA9BA-DCD8-4D5D-8004-57CBAC31ED74</gtr:id><gtr:title>Choice of transformation for modelling non-linear continuous biomarkers</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b428e3a642b26c293498e9f3af8317"><gtr:id>44b428e3a642b26c293498e9f3af8317</gtr:id><gtr:otherNames>Stocken D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>d9i7UEDjCtV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55536D12-15D6-400F-A3FB-357C87BF4927</gtr:id><gtr:title>Preoperative risk assessment for bleeding and thromboembolism.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/695c9b48f69465f14d7524e8e98968ea"><gtr:id>695c9b48f69465f14d7524e8e98968ea</gtr:id><gtr:otherNames>Arnold DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>TEWi3QkwnGi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC875175-8657-4DD1-9DE7-1C33B01ADEFC</gtr:id><gtr:title>Individual participant data meta-analyses compared with meta-analyses based on aggregate data</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2859f4b6c674aac6f0822025826c8b39"><gtr:id>2859f4b6c674aac6f0822025826c8b39</gtr:id><gtr:otherNames>Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>JUMBWwSav9S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B067EDC5-C4B0-41CD-9817-7250FA936E96</gtr:id><gtr:title>Assessment of ERCC1 in ongoing lung cancer trials</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>inyKvvU2A6f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61027156-5962-40D6-9999-6CCC91CDFC3A</gtr:id><gtr:title>Revascularization versus medical therapy for renal-artery stenosis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74794858bdafe130aa0196b2d8155fb1"><gtr:id>74794858bdafe130aa0196b2d8155fb1</gtr:id><gtr:otherNames>ASTRAL Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>PY4PJ2DV4vH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AE87233-E146-44AA-B3CC-BD806C9F8A5C</gtr:id><gtr:title>Development of a self-report measure of capability wellbeing for adults: the ICECAP-A.</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>JGEuqw5Zr8y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9645EAF-6647-4DAD-9FD7-9D4FAEEDC582</gtr:id><gtr:title>The challenges of interventional trials in fetal therapy.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df76bc9da5038380a288803261e4d6e7"><gtr:id>df76bc9da5038380a288803261e4d6e7</gtr:id><gtr:otherNames>Morris RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>585d59acb26f62.81617560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAEA3DA7-FF07-4DAF-A656-18A07F6254D2</gtr:id><gtr:title>Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a83b139c370622447f799add805cadb"><gtr:id>9a83b139c370622447f799add805cadb</gtr:id><gtr:otherNames>McMinn DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55f984984c648574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8AD4C87-D4C7-4B61-86CB-E420558EAD77</gtr:id><gtr:title>Individual participant data meta-analyses should not ignore clustering.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d762b6e6a56ac4f63c98cc923141e126"><gtr:id>d762b6e6a56ac4f63c98cc923141e126</gtr:id><gtr:otherNames>Abo-Zaid G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>pm_540e15fe15fcb1c75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF86C05C-C900-4CF8-9412-F3A529208D07</gtr:id><gtr:title>Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8dcd9a8ca9231cb47c4f3c4de48f137"><gtr:id>b8dcd9a8ca9231cb47c4f3c4de48f137</gtr:id><gtr:otherNames>Harrington KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>suLfaRKgK1Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03C9601A-1D1A-478D-8995-93A90E49876E</gtr:id><gtr:title>Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c35e0ed16228f62d4678e49013b5bec"><gtr:id>3c35e0ed16228f62d4678e49013b5bec</gtr:id><gtr:otherNames>Malottki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>HmxDeeN1z5L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47B27CEC-5547-42CA-9DF2-C3A4834D8457</gtr:id><gtr:title>Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses.</gtr:title><gtr:parentPublicationTitle>Annals of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71d7f40f94356d7678782b2f0f6136dc"><gtr:id>71d7f40f94356d7678782b2f0f6136dc</gtr:id><gtr:otherNames>Bowater RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-4932</gtr:issn><gtr:outcomeId>PVoh6xuyjjD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4506F19-B5D8-4A23-A4F7-41E01516F9EB</gtr:id><gtr:title>Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/789b1ce9ea2ea7376f753269cb93f8c4"><gtr:id>789b1ce9ea2ea7376f753269cb93f8c4</gtr:id><gtr:otherNames>Halligan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>YkHnPMJBcP6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44DCE9A8-2134-42F0-BF72-8C06DCA79811</gtr:id><gtr:title>Fatigue, psychological and cognitive impairment following transient ischaemic attack and minor stroke: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ca661304b63f777d416a6b8e069c55"><gtr:id>93ca661304b63f777d416a6b8e069c55</gtr:id><gtr:otherNames>Moran GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>doi_55faa1aa1e1b76f8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F64E95DF-91B6-49CD-85C2-D8D95AB2D5B7</gtr:id><gtr:title>Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c6da75910dc0b588a6d18d11524ab9f"><gtr:id>4c6da75910dc0b588a6d18d11524ab9f</gtr:id><gtr:otherNames>Kyte D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463acc8ed68c2.08154573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2B2321E-3CB1-4DC6-849D-B210CB388CC4</gtr:id><gtr:title>Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/745e53f4056b8e3888d31d91becbb6f4"><gtr:id>745e53f4056b8e3888d31d91becbb6f4</gtr:id><gtr:otherNames>Chen YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>doi_55f984984c42e690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A6E4BE8-16DD-4539-BC3F-1E4B4C884ACB</gtr:id><gtr:title>SPI evaluation team (2011) Safer Patients Initiative phase two: A controlled evaluation of the second phase of a complex patient safety intervention implemented in English hospitals</gtr:title><gtr:parentPublicationTitle>The Health Foundation, London</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6ab50ee0ebbe9a337d391aebb9ff0ea"><gtr:id>e6ab50ee0ebbe9a337d391aebb9ff0ea</gtr:id><gtr:otherNames>SPI evaluation team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>9781906461225</gtr:isbn><gtr:outcomeId>ct6csXP841o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F442D780-B3CD-4285-AF21-50833D40BFB0</gtr:id><gtr:title>Meta-analysis of a continuous outcome combining individual patient data and aggregate data: a method based on simulated individual patient data.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15db6d6ac8ebcc9e1351148cf9e118a3"><gtr:id>15db6d6ac8ebcc9e1351148cf9e118a3</gtr:id><gtr:otherNames>Yamaguchi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>doi_55f984984c37c81a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20F76D67-3B73-4591-9310-B82F7A9B8613</gtr:id><gtr:title>Methodological considerations in the evaluation of radiotherapy technologies.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d9390b0c0b53671de712307f15a06f1"><gtr:id>6d9390b0c0b53671de712307f15a06f1</gtr:id><gtr:otherNames>Burnet NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>Aws4Nj7tBa7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DC96AF5-85ED-45FB-AB7D-14C802A9B281</gtr:id><gtr:title>Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia</gtr:title><gtr:parentPublicationTitle>BMC MEDICAL RESEARCH METHODOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd97b5dcf8091c73ed2991fceb50bed1"><gtr:id>fd97b5dcf8091c73ed2991fceb50bed1</gtr:id><gtr:otherNames>Yap Christina</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>J7SCtRife3y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F97E9942-0E02-4863-B465-7357DE55C9A4</gtr:id><gtr:title>Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bd811a5fe1bfd6f608c2b2af9425977"><gtr:id>6bd811a5fe1bfd6f608c2b2af9425977</gtr:id><gtr:otherNames>Ahmed I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>TrefgSNNCgK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>965AAC7F-8CC5-4072-B0B2-A21CB6B99AA8</gtr:id><gtr:title>Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0205c2ac34e9cd16ccca71f123e81580"><gtr:id>0205c2ac34e9cd16ccca71f123e81580</gtr:id><gtr:otherNames>Yu LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>eG4ZcR6MMGS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB6EF87-2640-4A69-95E9-46058E387CA4</gtr:id><gtr:title>Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c6da75910dc0b588a6d18d11524ab9f"><gtr:id>4c6da75910dc0b588a6d18d11524ab9f</gtr:id><gtr:otherNames>Kyte D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>FCadNL1okec</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D67CE1B-D9B1-4382-B74E-610E32FD1C9A</gtr:id><gtr:title>A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56aea84ff458ec65c4b7eb8d247b357b"><gtr:id>56aea84ff458ec65c4b7eb8d247b357b</gtr:id><gtr:otherNames>Andronis L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56def2235316c1.69927258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F860A8EA-D981-415F-8223-7E8FA25015B6</gtr:id><gtr:title>Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65d62331c47a6cf1a25f9b4d2c4d1743"><gtr:id>65d62331c47a6cf1a25f9b4d2c4d1743</gtr:id><gtr:otherNames>Toulis KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5675dfe26464b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A3E3EE8-86C9-4CCC-9323-3B4D826EC2FB</gtr:id><gtr:title>A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf298f8320984a85385a5b029ede647"><gtr:id>daf298f8320984a85385a5b029ede647</gtr:id><gtr:otherNames>Ferrante di Ruffano L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>BwCtBNE6mPW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DE0A98A-21CD-4BEB-A1F7-32CB5455CD2C</gtr:id><gtr:title>Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c256ffa6a4c42f828c8e2100a19f1f9d"><gtr:id>c256ffa6a4c42f828c8e2100a19f1f9d</gtr:id><gtr:otherNames>Bakir M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>gpNGWA9qU5s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A127A981-7BE7-48E5-90E0-1D8E5BE88A99</gtr:id><gtr:title>Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/366629869aa959e7e6a4e2db47d282f1"><gtr:id>366629869aa959e7e6a4e2db47d282f1</gtr:id><gtr:otherNames>Coast J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>UuK1JMP6Qwh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13353DC9-EBA6-443B-897B-667897E756B2</gtr:id><gtr:title>Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.</gtr:title><gtr:parentPublicationTitle>Proteomics. Clinical applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8d77c5878c73e314c74fdbf52168dc7"><gtr:id>a8d77c5878c73e314c74fdbf52168dc7</gtr:id><gtr:otherNames>Bryan RT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1862-8346</gtr:issn><gtr:outcomeId>p3iGVM1nysh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A127B985-D9B6-4CAD-BB77-1A18DD3B8A0B</gtr:id><gtr:title>Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial).</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/764a709c164324cfea6b1ed549bc834d"><gtr:id>764a709c164324cfea6b1ed549bc834d</gtr:id><gtr:otherNames>Pinkney TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>XSEPPCgS4UR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F9AA5B-5A36-4A36-8E48-E40D29806085</gtr:id><gtr:title>Systematic review finds major deficiencies in sample size methodology and reporting for stepped-wedge cluster randomised trials.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b00276518bd4961cf04fe7b47dc61cd9"><gtr:id>b00276518bd4961cf04fe7b47dc61cd9</gtr:id><gtr:otherNames>Martin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d5345a669d5.01906604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFC4E8E1-6161-463D-A81F-083EB42496FA</gtr:id><gtr:title>Evaluation of Lay Support in Pregnant women with Social risk (ELSIPS): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC pregnancy and childbirth</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac91d594c7e90381df2cf61e9aa41f26"><gtr:id>ac91d594c7e90381df2cf61e9aa41f26</gtr:id><gtr:otherNames>Kenyon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2393</gtr:issn><gtr:outcomeId>BuY6rqinnDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>210FCB8E-5F20-479D-94A4-423EFC681473</gtr:id><gtr:title>Radiotherapy research priorities for the UK.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e96a47f840e64fa213f5d842daf1e753"><gtr:id>e96a47f840e64fa213f5d842daf1e753</gtr:id><gtr:otherNames>Maughan TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>djaQndyfE1C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B920DCB-6E13-4C38-AC41-6FD458309768</gtr:id><gtr:title>A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2312edc6e4c6dd0389103170474aad6"><gtr:id>e2312edc6e4c6dd0389103170474aad6</gtr:id><gtr:otherNames>Meadows A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>XzH2rSeLzBo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E7DCC1-A54B-4B6D-A1A0-56648A5D900C</gtr:id><gtr:title>Fetal growth and birthweight standards as screening tools: methods for evaluating performance.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>X3AViLhCBbR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>095AAAA3-5D05-4204-A600-65B724D7E75C</gtr:id><gtr:title>Reporting quality of life in clinical trials: a CONSORT extension.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>WgX7DBycCVj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AFF26B3-528E-4412-BA2E-B32E30B71C98</gtr:id><gtr:title>Population health status of South Asian and African-Caribbean communities in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>doi_55f984984c948394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B639A6-2D58-4095-8D2D-C0BB0A2506DE</gtr:id><gtr:title>Using hospital mortality rates to judge hospital performance: a bad idea that just won't go away.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2949feb6e6ca42154deee5895dcf1dcd"><gtr:id>2949feb6e6ca42154deee5895dcf1dcd</gtr:id><gtr:otherNames>Lilford R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>oKCmLrx5UKb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B1DBA2-F3AB-4811-A373-3A1891C4F50B</gtr:id><gtr:title>A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c9d1b02ecba3fca9a1898d6c28cfd4"><gtr:id>76c9d1b02ecba3fca9a1898d6c28cfd4</gtr:id><gtr:otherNames>Debray TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>bu66rKZtrhT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C827FBBE-2FC6-44DE-AD78-1E13E15419A1</gtr:id><gtr:title>Approaches to the evaluation of rapidly evolving technologies</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>Ca6vu9ZTwvc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E70C8FD9-4EEB-4775-A3E3-3F769E6C96D1</gtr:id><gtr:title>How do the information needs of cancer patients differ at different stages of the cancer journey? A cross-sectional survey.</gtr:title><gtr:parentPublicationTitle>JRSM short reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53bc0fb1a354d00d3b1cd6f001acd819"><gtr:id>53bc0fb1a354d00d3b1cd6f001acd819</gtr:id><gtr:otherNames>Mistry A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2042-5333</gtr:issn><gtr:outcomeId>ZJ4kcqkjAh4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09CDABF-ABD6-4563-B3F6-E1421B1F7FAD</gtr:id><gtr:title>Early-stage valuation of medical devices: the role of developmental uncertainty.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44c7a6c849cd02a046edad22a60cdc57"><gtr:id>44c7a6c849cd02a046edad22a60cdc57</gtr:id><gtr:otherNames>Girling A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>fBAbcHGa8ja</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B5DA1D1-08FC-4238-ACCA-62707B7C1FC7</gtr:id><gtr:title>Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.</gtr:title><gtr:parentPublicationTitle>BMC family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/717fb6acab2e2d5beb5c1a5b65903b70"><gtr:id>717fb6acab2e2d5beb5c1a5b65903b70</gtr:id><gtr:otherNames>Arnold DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2296</gtr:issn><gtr:outcomeId>PG3UKvixU2M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>729C04EF-5749-49F9-924D-4C9C88A9049C</gtr:id><gtr:title>Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf298f8320984a85385a5b029ede647"><gtr:id>daf298f8320984a85385a5b029ede647</gtr:id><gtr:otherNames>Ferrante di Ruffano L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5a2fd8dc3b69c7.26785947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57444D3B-0DE0-4002-BFBE-DD61B02E8B7C</gtr:id><gtr:title>Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd7aeff97fa7f6be6bd2add4c47214bf"><gtr:id>cd7aeff97fa7f6be6bd2add4c47214bf</gtr:id><gtr:otherNames>Marshall T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>XMn56nnXTzf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F3C079E-CDDA-41DF-B334-2E9FF298D4AE</gtr:id><gtr:title>A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: economic evaluation.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/218b1b5f0715d058057c83ec846cfdf7"><gtr:id>218b1b5f0715d058057c83ec846cfdf7</gtr:id><gtr:otherNames>Hollinghurst S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>Sfq67g4GXW6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5BDB03F-6F1F-473B-BAD3-7D70BAD3CDD5</gtr:id><gtr:title>How are centres included in randomised controlled trials with parallel economic evaluations in the uk?</gtr:title><gtr:parentPublicationTitle>Value in Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/105bb5b723c6b9e55c5a4c2383652ce3"><gtr:id>105bb5b723c6b9e55c5a4c2383652ce3</gtr:id><gtr:otherNames>Gheorghe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>M45HbnZ3DSu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B35F119F-4C28-415D-85A7-5A689FB1C77D</gtr:id><gtr:title>Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b27010449fcf1321adae4e3e9e3a6ea8"><gtr:id>b27010449fcf1321adae4e3e9e3a6ea8</gtr:id><gtr:otherNames>Macafee DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>fPbCPpcaRNL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8175E1C9-E91F-4EC7-BB8F-90F04A700855</gtr:id><gtr:title>Summarising and validating test accuracy results across multiple studies for use in clinical practice.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5675e13e7e88c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04041FDF-744F-45B2-B0FA-56C2D6C7AC95</gtr:id><gtr:title>Meta-analysis of a binary outcome using individual participant data and aggregate data.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>nM2MPhgR97Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C0BD295-F90E-459C-A34C-D6EBECE755CA</gtr:id><gtr:title>Pooling systematic reviews of systematic reviews: a Bayesian panoramic meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>KduGvDxW26T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D447290-2D60-4E00-91F5-3686979199B7</gtr:id><gtr:title>Meta-analysis of test accuracy studies: an exploratory method for investigating the impact of missing thresholds.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>585d5915c92823.71966724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D42611A-F524-4ADC-A27E-FF971E06E420</gtr:id><gtr:title>A qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a02c8ac740b6e5834f02387a5ba7b0"><gtr:id>26a02c8ac740b6e5834f02387a5ba7b0</gtr:id><gtr:otherNames>Keeley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>KBQdFANCm5R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A3A361-06CE-459C-9F65-3A4492FF37B5</gtr:id><gtr:title>Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8da950e2f99c70d5b36b5757ab768668"><gtr:id>8da950e2f99c70d5b36b5757ab768668</gtr:id><gtr:otherNames>Lilford RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>tABatg9MG1t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>037A3BA5-D3B0-48F8-B74B-3DFD9012327D</gtr:id><gtr:title>The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer.</gtr:title><gtr:parentPublicationTitle>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683f15bc84737d29fc6068129f342f9e"><gtr:id>683f15bc84737d29fc6068129f342f9e</gtr:id><gtr:otherNames>Dinnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0820-3946</gtr:issn><gtr:outcomeId>nFwFMbdSKpE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFDFC135-67FC-4400-9E47-B11CD782C8C4</gtr:id><gtr:title>Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c131d6c428e1ab3d14c43ed9e3d897"><gtr:id>42c131d6c428e1ab3d14c43ed9e3d897</gtr:id><gtr:otherNames>Bartlett JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>tDhQBYcqMJo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD665EB6-A963-43B2-AFB5-78E1A07874F5</gtr:id><gtr:title>Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/663dbee7099f5029f702b8637bd8f9ee"><gtr:id>663dbee7099f5029f702b8637bd8f9ee</gtr:id><gtr:otherNames>Kenemans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>DmcDS1jioJD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35B67442-5F49-42B1-822B-F31241668DCA</gtr:id><gtr:title>Joint Modelling of Quality of Life and Survival in a Randomised Cancer Trial Data: Sensitivity of Results to Model Choice</gtr:title><gtr:parentPublicationTitle>Journal ofClinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/397f4678931b076cb7427722353ef0d6"><gtr:id>397f4678931b076cb7427722353ef0d6</gtr:id><gtr:otherNames>Yap,C</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>SBrsDjnC2NX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>463AB7C3-9666-4539-AEE5-80B7EDFDCE2F</gtr:id><gtr:title>Evaluation of methods to adjust for treatment switching in clinical trials</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1756b60339c2b292fb26172c28009caa"><gtr:id>1756b60339c2b292fb26172c28009caa</gtr:id><gtr:otherNames>Fox R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>VeM6isUDYJ4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B35D7A8D-1419-44A4-AD5D-1470A2910EBB</gtr:id><gtr:title>Can capabilities be self-reported? A think aloud study.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>KoR8rBThz2Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BFDA50F-836C-412E-8471-2DCD16697AC2</gtr:id><gtr:title>Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df76bc9da5038380a288803261e4d6e7"><gtr:id>df76bc9da5038380a288803261e4d6e7</gtr:id><gtr:otherNames>Morris RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>pm_540e160e1600410c5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CE8E621-476C-495E-8FAA-F529A05182C5</gtr:id><gtr:title>Three-year efficacy of complex insulin regimens in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60aa245387cc0eef03ff248f96c39ef7"><gtr:id>60aa245387cc0eef03ff248f96c39ef7</gtr:id><gtr:otherNames>Holman RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>KPsAb65cBnz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5E12A49-4D05-4BE6-85FD-4B5713D0AD85</gtr:id><gtr:title>Patient-reported outcome alert monitoring.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/355faac86891632952432ee08412b267"><gtr:id>355faac86891632952432ee08412b267</gtr:id><gtr:otherNames>Thombs BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_540e15fe15fe2804b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DD33063-4FB3-4A60-A3D9-C91C8284E6C4</gtr:id><gtr:title>Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a05045e52fb49aa1d028fc7d67432676"><gtr:id>a05045e52fb49aa1d028fc7d67432676</gtr:id><gtr:otherNames>Atkin W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>KBfRT2otz1Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3261335-9CE5-40EF-B63D-808AA840FB4F</gtr:id><gtr:title>Sorafenib for liver cancer: the horizon broadens.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ad34c33181fa17e8ca6f19f78bcbfb6"><gtr:id>0ad34c33181fa17e8ca6f19f78bcbfb6</gtr:id><gtr:otherNames>Johnson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>HfCmU9j8EAm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3892E1EA-9D15-4D27-B721-F98A4AE21E39</gtr:id><gtr:title>What potential research participants want to know about research: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca60020e3351be5855014abf1dbbf5bd"><gtr:id>ca60020e3351be5855014abf1dbbf5bd</gtr:id><gtr:otherNames>Kirkby HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>HndrLjBKZAp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B653F6DF-562F-4ED7-A44B-788CAC6B57B8</gtr:id><gtr:title>QALYs and carers.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>fcJnCH5CUbP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC2B8972-7764-428C-8B39-A4CF0A7A3D15</gtr:id><gtr:title>Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>UXB7bKwCnPu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F325F8D-1F78-4187-A64A-A7C0F2847127</gtr:id><gtr:title>Development of a combined database for meta-epidemiological research.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>ARNaoegisYc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10732B50-6C98-4846-BA73-5B6A845E7EED</gtr:id><gtr:title>Intra-cluster and inter-period correlation coefficients for cross-sectional cluster randomised controlled trials for type-2 diabetes in UK primary care.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b00276518bd4961cf04fe7b47dc61cd9"><gtr:id>b00276518bd4961cf04fe7b47dc61cd9</gtr:id><gtr:otherNames>Martin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d6799cb29f2.89619667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EB9CCAC-6537-437E-8161-CB6A5C7E6199</gtr:id><gtr:title>Crossing survival curves: alternatives to the log-rank test</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dabee68563bf84822f0d7aab534bd51"><gtr:id>2dabee68563bf84822f0d7aab534bd51</gtr:id><gtr:otherNames>Bouliotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>aKwNVTnyyzQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3E5EA3F-05B0-4BDD-8B04-B7A7CEBE081E</gtr:id><gtr:title>Centre selection for clinical trials and the generalisability of results: a mixed methods study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/105bb5b723c6b9e55c5a4c2383652ce3"><gtr:id>105bb5b723c6b9e55c5a4c2383652ce3</gtr:id><gtr:otherNames>Gheorghe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Cku9PDdGRtM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06953C12-24B3-411D-B5E8-8B4B07EB526A</gtr:id><gtr:title>A menu-driven facility for sample-size calculations in cluster randomized controlled trials</gtr:title><gtr:parentPublicationTitle>STATA JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b11a753e5c228a967ec4a5e924084de6"><gtr:id>b11a753e5c228a967ec4a5e924084de6</gtr:id><gtr:otherNames>Hemming Karla</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1536-867X</gtr:issn><gtr:outcomeId>ViVSbxMgy9m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91E46230-3406-4EA4-8C04-1874658C3B36</gtr:id><gtr:title>A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17f519190d217d4e666d854dbdf4787"><gtr:id>a17f519190d217d4e666d854dbdf4787</gtr:id><gtr:otherNames>Kirkham JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>pGgp4D1K2kc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9896FB59-5772-4DA6-84F8-714D36248CED</gtr:id><gtr:title>Module evaluation: a comparison of standard evaluation with nominal group technique.</gtr:title><gtr:parentPublicationTitle>Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f79b46a69f9cc388264c940851814b"><gtr:id>07f79b46a69f9cc388264c940851814b</gtr:id><gtr:otherNames>Ives J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-9879</gtr:issn><gtr:outcomeId>pm_16423_23_23498578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADF9374D-03B8-4774-9F9D-DA66D31D4974</gtr:id><gtr:title>Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e23bf6872e4e1b4f62d290abd99df515"><gtr:id>e23bf6872e4e1b4f62d290abd99df515</gtr:id><gtr:otherNames>Vallejo-Torres L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>cwCEGc6Mbbt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38FE3EF0-D5D4-4998-9CE2-973861C58678</gtr:id><gtr:title>Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a330ee51df175e2726c4fdc40df29be"><gtr:id>6a330ee51df175e2726c4fdc40df29be</gtr:id><gtr:otherNames>Boggild M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>JU1P9fhTzUa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB4A1E09-B2AF-429A-92EA-65DC5AEBBB4A</gtr:id><gtr:title>Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d640d20f04c76ec71da809afc9b753e"><gtr:id>1d640d20f04c76ec71da809afc9b753e</gtr:id><gtr:otherNames>Ensor J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>Sj8uVDwcLDP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A78D3E1D-6BE1-4BF4-8D3A-8374557FEB20</gtr:id><gtr:title>'Choice is a small word with a huge meaning': autonomy and decision making at the end of life</gtr:title><gtr:parentPublicationTitle>Policy &amp; Politics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7c4714f07f20291e49c99e9c60b1e3b"><gtr:id>f7c4714f07f20291e49c99e9c60b1e3b</gtr:id><gtr:otherNames>Sutton E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>TjJivC5VYTM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22060820-3CD9-42A4-B833-EBBC428258D5</gtr:id><gtr:title>A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/783a1a1910d70519c37242956f10c439"><gtr:id>783a1a1910d70519c37242956f10c439</gtr:id><gtr:otherNames>Pennant M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>KgN1dFkDikB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CC32E7C-8D2F-4652-9F24-24F6E7526663</gtr:id><gtr:title>A matrix-based method of moments for fitting the multivariate random effects model for meta-analysis and meta-regression.</gtr:title><gtr:parentPublicationTitle>Biometrical journal. Biometrische Zeitschrift</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0323-3847</gtr:issn><gtr:outcomeId>NP3z78Et1bE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D49A768-1FC3-4784-93E1-D6BEAAADBD95</gtr:id><gtr:title>Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study.</gtr:title><gtr:parentPublicationTitle>American heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d64fd35662badfaf6402abff484db4d8"><gtr:id>d64fd35662badfaf6402abff484db4d8</gtr:id><gtr:otherNames>Cleland JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-8703</gtr:issn><gtr:outcomeId>Hp2t3dbaXU4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C70B8EF6-5213-47AB-9D14-C7D161CCC5F2</gtr:id><gtr:title>Effect of antenatal peer support on breastfeeding initiation: a systematic review.</gtr:title><gtr:parentPublicationTitle>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edaa3d5159d0557a59988fc480ba6f"><gtr:id>52edaa3d5159d0557a59988fc480ba6f</gtr:id><gtr:otherNames>Ingram L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0820-3946</gtr:issn><gtr:outcomeId>TZ26iEzMcPo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7338BA7-398E-44A8-940C-924E08D6D755</gtr:id><gtr:title>Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c35e0ed16228f62d4678e49013b5bec"><gtr:id>3c35e0ed16228f62d4678e49013b5bec</gtr:id><gtr:otherNames>Malottki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5463b1feb0a897.59824958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54346AD4-D0B6-4038-A2E4-6CE2B78D5EB7</gtr:id><gtr:title>Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c7fa02a583838932b969061b1434dcd"><gtr:id>2c7fa02a583838932b969061b1434dcd</gtr:id><gtr:otherNames>Mant J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>A9g5YcNw48y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5323263-E766-430A-9EEF-CA8A3021FA2B</gtr:id><gtr:title>Challenges in evaluating surgical innovation.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31ca129d1631e4bfeb189ba6e06b416"><gtr:id>f31ca129d1631e4bfeb189ba6e06b416</gtr:id><gtr:otherNames>Ergina PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>FNzusSFQtbt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75280841-5C3C-44AC-A2EE-8E7B441A1E32</gtr:id><gtr:title>No surgical innovation without evaluation: the IDEAL recommendations.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a85fcd8813ddb948d8454a21ddb5807"><gtr:id>6a85fcd8813ddb948d8454a21ddb5807</gtr:id><gtr:otherNames>McCulloch P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>J8buS6t4SrP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AB698EB-DA31-4DF1-A804-BBACCC0D3C8D</gtr:id><gtr:title>Bayesian cohort and cross-sectional analyses of the PINCER trial: a pharmacist-led intervention to reduce medication errors in primary care.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>HWqF8Diispe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFD90468-BF9B-4E13-B092-52BFCC32B07A</gtr:id><gtr:title>Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4a1494d86ef128719d40e4ef20114e"><gtr:id>9b4a1494d86ef128719d40e4ef20114e</gtr:id><gtr:otherNames>Raichand S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>GSV4zx8Bfcj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF5AD693-80B8-4B09-9DD6-42011B11F3FF</gtr:id><gtr:title>Anti-epileptic drug harms: issues for meta-analysis</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2859f4b6c674aac6f0822025826c8b39"><gtr:id>2859f4b6c674aac6f0822025826c8b39</gtr:id><gtr:otherNames>Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>ex9EgSWEKz5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78E3DF3B-18EC-4409-84E6-6156DFC90F7B</gtr:id><gtr:title>Meta-analysis of randomized phase II trials to inform subsequent phase III decisions.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52295d594ac365229f85d5d07e8e057b"><gtr:id>52295d594ac365229f85d5d07e8e057b</gtr:id><gtr:otherNames>Burke DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5463b07f656616.02663131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EB0ED5C-6347-4EE6-B9E7-0870E4AD1626</gtr:id><gtr:title>The West Midlands Bladder Cancer Prognosis Programme: rationale and design.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eec2f15f542ae210191e79e8ec0e3eec"><gtr:id>eec2f15f542ae210191e79e8ec0e3eec</gtr:id><gtr:otherNames>Zeegers MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>FZUPuTL5rbC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2CF04B2-9432-404F-94CD-F71E6B76D8AC</gtr:id><gtr:title>Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14f21c098907802100e4488ee4bed78c"><gtr:id>14f21c098907802100e4488ee4bed78c</gtr:id><gtr:otherNames>Steele JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>EimGF3DQPLX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>672A5A72-5CBF-4784-82A4-28B420C0EDBF</gtr:id><gtr:title>Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure.</gtr:title><gtr:parentPublicationTitle>Applied health economics and health policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0144e58ef16cefa7e2d015997ecb426"><gtr:id>b0144e58ef16cefa7e2d015997ecb426</gtr:id><gtr:otherNames>Flynn TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1175-5652</gtr:issn><gtr:outcomeId>Dowr1YwHioM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40021E4C-68AE-4FD0-B49C-400E624CA387</gtr:id><gtr:title>Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery</gtr:title><gtr:parentPublicationTitle>Clinical Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4f109d69b696f3f67cb35ca90dd3201"><gtr:id>a4f109d69b696f3f67cb35ca90dd3201</gtr:id><gtr:otherNames>Rathinam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>870C341F3CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D48D5DA-4200-4485-B841-E9BCAFB89945</gtr:id><gtr:title>An analysis of the complementarity of ICECAP-A and EQ-5D-3 L in an adult population of patients with knee pain.</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a02c8ac740b6e5834f02387a5ba7b0"><gtr:id>26a02c8ac740b6e5834f02387a5ba7b0</gtr:id><gtr:otherNames>Keeley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>585d5246940850.46697089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A2CE24D-9B65-4540-B79A-C14D6359C301</gtr:id><gtr:title>Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b19ed23372dae5b7a38361522a0300cc"><gtr:id>b19ed23372dae5b7a38361522a0300cc</gtr:id><gtr:otherNames>Snell KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>585d589812b778.03111154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8860860-A750-4F6B-AF26-E60E3CDED6A0</gtr:id><gtr:title>Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>fRfrtQ8rTVi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF726F1F-75E2-45F8-8D78-527FBA29C7BB</gtr:id><gtr:title>Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c958e7738e076f644092ecd72ea3d0d"><gtr:id>8c958e7738e076f644092ecd72ea3d0d</gtr:id><gtr:otherNames>Ewer AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>Hmhh5eVJ5pb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>012E99D2-DD08-45E1-810B-886EF22DDDC4</gtr:id><gtr:title>Band slippage and erosion after laparoscopic gastric banding: a meta-analysis.</gtr:title><gtr:parentPublicationTitle>Surgical endoscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/072eba4014ebe2aeef76d1335e2c9eaf"><gtr:id>072eba4014ebe2aeef76d1335e2c9eaf</gtr:id><gtr:otherNames>Singhal R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0930-2794</gtr:issn><gtr:outcomeId>Qq5KKaahSix</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBFE3AA7-9A8D-417D-B1C4-EB0999572D16</gtr:id><gtr:title>Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c046ae6f178734e3c27748ade971b75c"><gtr:id>c046ae6f178734e3c27748ade971b75c</gtr:id><gtr:otherNames>Brundage M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>m8XQkBR3rTz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A9D2D5-E9C1-43FF-9AED-5716BD18D6CF</gtr:id><gtr:title>Stepped wedge cluster randomized trials are efficient and provide a method of evaluation without which some interventions would not be evaluated.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>r3RhtPw8ivH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>966AD57F-FCA2-4701-9656-5B5893B3F473</gtr:id><gtr:title>Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df76bc9da5038380a288803261e4d6e7"><gtr:id>df76bc9da5038380a288803261e4d6e7</gtr:id><gtr:otherNames>Morris RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>d8Jvbd8Tp33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDD61119-96CA-4E86-8598-5B4316B6A64E</gtr:id><gtr:title>Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62d103499bf572c436778749e87ca85b"><gtr:id>62d103499bf572c436778749e87ca85b</gtr:id><gtr:otherNames>Wood S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>doi_55f984984c556697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D401876-6928-428A-AD24-C913F1F32B05</gtr:id><gtr:title>Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures?</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b19ed23372dae5b7a38361522a0300cc"><gtr:id>b19ed23372dae5b7a38361522a0300cc</gtr:id><gtr:otherNames>Snell KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>5a2fd793e7bb66.28572729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B79BFBA-B0DD-49E3-8796-84164411273F</gtr:id><gtr:title>Developing and validating risk prediction models in an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bd811a5fe1bfd6f608c2b2af9425977"><gtr:id>6bd811a5fe1bfd6f608c2b2af9425977</gtr:id><gtr:otherNames>Ahmed I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5463b2c4db3566.99660534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25054F1D-4DF4-4D47-9D53-EFB3597E1272</gtr:id><gtr:title>A menu driven facility for sample size calculations in cluster randomised controlled trials</gtr:title><gtr:parentPublicationTitle>The Stata Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33a009c12332aaa8b84323ac4462a2ff"><gtr:id>33a009c12332aaa8b84323ac4462a2ff</gtr:id><gtr:otherNames>Hemming,K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>Juf3t3dVkEm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C34CE5F-966D-408C-B0F2-644DD251DBD7</gtr:id><gtr:title>Meta-analysis of individual participant data: rationale, conduct, and reporting.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>XFB3Wn78snt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A522CEF2-D940-4EF5-B940-7B607AE2D7F8</gtr:id><gtr:title>Predicting the ICECAP-O capability index from the WOMAC osteoarthritis index: is mapping onto capability from condition-specific health status questionnaires feasible?</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1016d456076a3392869dc10c9ddb06a"><gtr:id>f1016d456076a3392869dc10c9ddb06a</gtr:id><gtr:otherNames>Mitchell PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>NxbWgTYx9nM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F00992B-90CB-4839-8EAC-04F0C8EB1C56</gtr:id><gtr:title>Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3831ec5bd89c3962028a071efc9680e2"><gtr:id>3831ec5bd89c3962028a071efc9680e2</gtr:id><gtr:otherNames>Girling AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>585d6793ceeae4.90250798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E5EE63D-8874-4258-A938-21E1EEC22AE2</gtr:id><gtr:title>Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a15cb74bcd03687d959cb088e322ed7"><gtr:id>4a15cb74bcd03687d959cb088e322ed7</gtr:id><gtr:otherNames>Benning A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>EAZjFnHTV2Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B413F6-A7DC-47AA-877D-B209726E3F2C</gtr:id><gtr:title>Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluation.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a15cb74bcd03687d959cb088e322ed7"><gtr:id>4a15cb74bcd03687d959cb088e322ed7</gtr:id><gtr:otherNames>Benning A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>eZDhBaKS3Fc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF5C8C83-37E8-4842-BFE5-32FC169070F7</gtr:id><gtr:title>Patients' experiences of deep brain stimulation for Parkinson's disease: a qualitative systematic review and synthesis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6bd71fff29284a2aa9e891cdae4e377"><gtr:id>d6bd71fff29284a2aa9e891cdae4e377</gtr:id><gtr:otherNames>Mathers J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d6796b5f705.49346896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>102C4A84-DDAB-4212-978F-FF18BB9F8AC0</gtr:id><gtr:title>Comparing the implementation of a Modified Continual Reassessment Method to a 3+3 Design in a Phase I Acute Myeloid Leukaemia Trial</gtr:title><gtr:parentPublicationTitle>Clin Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da228590f1d8180e3b5c35ebb96f8623"><gtr:id>da228590f1d8180e3b5c35ebb96f8623</gtr:id><gtr:otherNames>Yap C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>bmDv3kB64Hj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1070EE95-B6D0-43DD-92C9-85E52C710878</gtr:id><gtr:title>Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohorts.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543edfdc78c798a9342a95b8ba7fc5da"><gtr:id>543edfdc78c798a9342a95b8ba7fc5da</gtr:id><gtr:otherNames>Bessell EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>LTEkY5aARjC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4AA01DF-7D0B-4EBF-A5CF-404BB4ECFB15</gtr:id><gtr:title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.</gtr:title><gtr:parentPublicationTitle>International journal of surgery (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66421cc7e1c06d7a65ea20ee3bdf4817"><gtr:id>66421cc7e1c06d7a65ea20ee3bdf4817</gtr:id><gtr:otherNames>Moher D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1743-9159</gtr:issn><gtr:outcomeId>LgGu4BNAvhi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E092100-6354-4764-BE82-BE6197F81848</gtr:id><gtr:title>Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9119e7ebc39bfadd45b3959d589eb146"><gtr:id>9119e7ebc39bfadd45b3959d589eb146</gtr:id><gtr:otherNames>Song F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>sHaVdzwzXXr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3554E1F0-BFD9-45B8-B03C-725AE0D17FDA</gtr:id><gtr:title>Bayesian meta-analysis on medical devices: application to implantable cardioverter defibrillators.</gtr:title><gtr:parentPublicationTitle>International journal of technology assessment in health care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a3f8206e45fe6fcad8b25e6c834162e"><gtr:id>4a3f8206e45fe6fcad8b25e6c834162e</gtr:id><gtr:otherNames>Youn JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0266-4623</gtr:issn><gtr:outcomeId>BPLX6mrHZ2P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15CF4FA0-F4B8-4B3E-97B9-727F016319D4</gtr:id><gtr:title>Individual patient data meta-analysis of survival data using Poisson regression models.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2057c985c76e13f0f2f14ab5e43ad32f"><gtr:id>2057c985c76e13f0f2f14ab5e43ad32f</gtr:id><gtr:otherNames>Crowther MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>P7s645SZF86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41587B7B-232D-4609-AEA1-3BFE01F370E4</gtr:id><gtr:title>Individual participant data meta-analysis for a binary outcome: one-stage or two-stage?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c9d1b02ecba3fca9a1898d6c28cfd4"><gtr:id>76c9d1b02ecba3fca9a1898d6c28cfd4</gtr:id><gtr:otherNames>Debray TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DXP8C8w3QmS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AF88FC-3E5A-48D1-9C2A-82190B01BAFD</gtr:id><gtr:title>Protocol for evaluation of the cost-effectiveness of ePrescribing systems and candidate prototype for other related health information technologies.</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8da950e2f99c70d5b36b5757ab768668"><gtr:id>8da950e2f99c70d5b36b5757ab768668</gtr:id><gtr:otherNames>Lilford RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>pm_540e160e1602227c3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8F8ED25-3A36-4AE3-AF3D-EF553EB3A880</gtr:id><gtr:title>Informing potential participants about research: observational study with an embedded randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca60020e3351be5855014abf1dbbf5bd"><gtr:id>ca60020e3351be5855014abf1dbbf5bd</gtr:id><gtr:otherNames>Kirkby HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>W2zAfJsSyny</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48D002FF-779E-41F1-B673-2EA491FC8E37</gtr:id><gtr:title>Small sample sizes in clinical trials: a statistician's perspective</gtr:title><gtr:parentPublicationTitle>Clinical Investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>XYZpyAjgdyX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88998C18-C76D-4099-9B5D-7385FBAC7455</gtr:id><gtr:title>Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/105bb5b723c6b9e55c5a4c2383652ce3"><gtr:id>105bb5b723c6b9e55c5a4c2383652ce3</gtr:id><gtr:otherNames>Gheorghe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>585d585a6868b6.48795084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183DEDF2-FE41-4D29-8794-10FF619DBD47</gtr:id><gtr:title>Prognosis research strategy (PROGRESS) 4: stratified medicine research.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f87a3660179f7a26dfc636854e4fec8"><gtr:id>1f87a3660179f7a26dfc636854e4fec8</gtr:id><gtr:otherNames>Hingorani AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55f984984c76e62f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEB0E5ED-11C5-4BFA-B1A8-612FE0AD42D0</gtr:id><gtr:title>Patient preferences for clinical follow-up after primary treatment for soft tissue sarcoma: a cross-sectional survey and discrete choice experiment.</gtr:title><gtr:parentPublicationTitle>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b68d0447459a264bff07910ed8013d6d"><gtr:id>b68d0447459a264bff07910ed8013d6d</gtr:id><gtr:otherNames>Damery S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0748-7983</gtr:issn><gtr:outcomeId>doi_55faa1aa1e11a2fc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1117D535-BF98-4CA3-8BD9-9185BAE4E639</gtr:id><gtr:title>Sample size calculations for cluster randomised controlled trials with a fixed number of clusters.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>RvZwxySjd5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60B873FF-72C6-4AF2-88C9-B84EC57F2224</gtr:id><gtr:title>Systematic review and meta-analysis of the value of clinical features to exclude radiographic pneumonia in febrile neutropenic episodes in children and young people.</gtr:title><gtr:parentPublicationTitle>Journal of paediatrics and child health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff8e811c5dae5e9ecc52ec4042d2d493"><gtr:id>ff8e811c5dae5e9ecc52ec4042d2d493</gtr:id><gtr:otherNames>Phillips B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1034-4810</gtr:issn><gtr:outcomeId>XGVRsB8DsKu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C4DE62-AE13-4B80-8BAD-8E8FEC444E9F</gtr:id><gtr:title>The Direct Comparative method: a innovative qualitative method of assessing content validity of quality of life measures</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1779c039a93ab8f2a372652d86c02157"><gtr:id>1779c039a93ab8f2a372652d86c02157</gtr:id><gtr:otherNames>Keeley,T</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>FHyjsJWCrAs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1954EB04-95BB-4BCC-AD0E-31B13CC132DA</gtr:id><gtr:title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66421cc7e1c06d7a65ea20ee3bdf4817"><gtr:id>66421cc7e1c06d7a65ea20ee3bdf4817</gtr:id><gtr:otherNames>Moher D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>CHYdApE5yox</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5F80F33-3869-424F-8B77-B5B89C46D04B</gtr:id><gtr:title>No evidence of bias in the process of publication of diagnostic accuracy studies in stroke submitted as abstracts.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b60e1b66dea5c8f00239c716ba13287"><gtr:id>8b60e1b66dea5c8f00239c716ba13287</gtr:id><gtr:otherNames>Brazzelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>MZWTPgNBogE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4F5BA8F-670D-4FBB-A616-79A19FF42BC4</gtr:id><gtr:title>Interpretation of random effects meta-analyses.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>cEyX2SUXeD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3018E98-BA96-468B-B00C-9FD6A64E7C27</gtr:id><gtr:title>Epidemiology and outcome of fracture of the hip in women aged 65 years and under: a cohort study.</gtr:title><gtr:parentPublicationTitle>The Journal of bone and joint surgery. British volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af89ca94ef348a125817dc083d93e48e"><gtr:id>af89ca94ef348a125817dc083d93e48e</gtr:id><gtr:otherNames>Karantana A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0301-620X</gtr:issn><gtr:outcomeId>DiaBFfeDSyk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4B11B62-638B-4031-85E9-4FEE3DE99335</gtr:id><gtr:title>Trials in rare diseases: the need to think differently</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>cxUKsJCU1x7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5490F4A9-E23B-46CB-97D3-9978E6E46024</gtr:id><gtr:title>Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ddbf12c0103e1e3623052d839b2cbec"><gtr:id>7ddbf12c0103e1e3623052d839b2cbec</gtr:id><gtr:otherNames>Arnold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>rKSet6JZDtK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F19423A-ED08-4177-B3A9-D5E606F69F79</gtr:id><gtr:title>An introduction to patient-reported outcome measures in ophthalmic research.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>doi_55f984984c4b7a74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CD5202D-9D57-423D-8795-845E8BF1B75D</gtr:id><gtr:title>Research methods to change clinical practice for patients with rare cancers.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>56def1dd9af898.14466367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18B4E4E4-1102-4452-A0D8-F8B247347C61</gtr:id><gtr:title>Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf298f8320984a85385a5b029ede647"><gtr:id>daf298f8320984a85385a5b029ede647</gtr:id><gtr:otherNames>Ferrante di Ruffano L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5a2fd6904d0a43.96651569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF56039D-45D2-4970-960A-67E6EACAEACE</gtr:id><gtr:title>Public preferences for colorectal cancer screening tests: a review of conjoint analysis studies.</gtr:title><gtr:parentPublicationTitle>Expert review of medical devices</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a92ef4a3c9d8459b9afd33ce1bd23f63"><gtr:id>a92ef4a3c9d8459b9afd33ce1bd23f63</gtr:id><gtr:otherNames>Ghanouni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-4440</gtr:issn><gtr:outcomeId>UyHfUsCPYMm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC6722A-E310-450B-A2CA-297421F3A8E0</gtr:id><gtr:title>Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bb45c4c7a5bcec753842366297e3e48"><gtr:id>3bb45c4c7a5bcec753842366297e3e48</gtr:id><gtr:otherNames>Hemingway H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>Ex9zH7BGTQs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B396C29D-CE19-47FC-82DC-2AF3A8B21D21</gtr:id><gtr:title>Evaluation of a predevelopment service delivery intervention: an application to improve clinical handovers.</gtr:title><gtr:parentPublicationTitle>BMJ quality &amp; safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c74d99a6b25f1b3727d5f3ec0138b8"><gtr:id>31c74d99a6b25f1b3727d5f3ec0138b8</gtr:id><gtr:otherNames>Yao GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2044-5415</gtr:issn><gtr:outcomeId>AjmTTwvduQU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CE73A5A-DBBD-4DED-8F13-B536BDFCEE98</gtr:id><gtr:title>Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/614e33f552501f394aac088b1d485b87"><gtr:id>614e33f552501f394aac088b1d485b87</gtr:id><gtr:otherNames>van Roekel EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>WeJ8fJNDMue</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C03F6E0-99CC-475F-88B3-C4FF11632700</gtr:id><gtr:title>Unexpected predictor-outcome associations in clinical prediction research: causes and solutions.</gtr:title><gtr:parentPublicationTitle>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2419908ee00b092283572c5a0d866f3e"><gtr:id>2419908ee00b092283572c5a0d866f3e</gtr:id><gtr:otherNames>Schuit E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0820-3946</gtr:issn><gtr:outcomeId>MbmPCgEQXZ7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B15214DD-3D53-47C3-8ECE-AE58D7353BC0</gtr:id><gtr:title>Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df76bc9da5038380a288803261e4d6e7"><gtr:id>df76bc9da5038380a288803261e4d6e7</gtr:id><gtr:otherNames>Morris RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55f984984c6d88e3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>499C3B90-86B6-4362-B1C9-C25F9C38247A</gtr:id><gtr:title>Comparison of models for estimation of long-term exposure to air pollution in cohort studies</gtr:title><gtr:parentPublicationTitle>Atmospheric Environment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e07d1beb078cbbdd90ed1ad2eb93fa2"><gtr:id>6e07d1beb078cbbdd90ed1ad2eb93fa2</gtr:id><gtr:otherNames>Beverland I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>LmoeRAeYhvM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EC70348-AAEC-416A-9ECD-785A1D68EE18</gtr:id><gtr:title>A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5cf2044dbb168aeab90cc02a6d8ea2"><gtr:id>9d5cf2044dbb168aeab90cc02a6d8ea2</gtr:id><gtr:otherNames>Tandon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>tA92547G5bf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C10CE614-EF20-4A1C-AECD-9770D108C8B8</gtr:id><gtr:title>Rational centre selection for RCTs with a parallel economic evaluation--the next step towards increased generalisability?</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/105bb5b723c6b9e55c5a4c2383652ce3"><gtr:id>105bb5b723c6b9e55c5a4c2383652ce3</gtr:id><gtr:otherNames>Gheorghe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>5463ade482aa55.63979785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40F91ECB-D273-4D9C-9C72-46A5A38DA912</gtr:id><gtr:title>Bayesian sensitivity models for missing covariates in the analysis of survival data.</gtr:title><gtr:parentPublicationTitle>Journal of evaluation in clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1356-1294</gtr:issn><gtr:outcomeId>HyydNqeeBLi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2FA7550-86B6-445F-BC9B-993DF266C590</gtr:id><gtr:title>The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice.</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>q1p6JHgsmGe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B87C0328-DFEC-47D5-931D-11B664782D21</gtr:id><gtr:title>Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3457936797ccbfd7d9ba22f0029cdf0e"><gtr:id>3457936797ccbfd7d9ba22f0029cdf0e</gtr:id><gtr:otherNames>Young AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>UafqQrN3QTF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>340C55F6-934B-4DAF-8573-D540FEAC68A7</gtr:id><gtr:title>Pricing of medical devices under coverage uncertainty--a modelling approach.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3831ec5bd89c3962028a071efc9680e2"><gtr:id>3831ec5bd89c3962028a071efc9680e2</gtr:id><gtr:otherNames>Girling AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>LuvJfYSu7cp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0E6B97A-B233-4D17-A503-EB07778D0798</gtr:id><gtr:title>Patient-reported outcome alerts: ethical and logistical considerations in clinical trials.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c6da75910dc0b588a6d18d11524ab9f"><gtr:id>4c6da75910dc0b588a6d18d11524ab9f</gtr:id><gtr:otherNames>Kyte D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>A33Acd4Bn4V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B35824C-8198-4B2E-B3B2-AA17D922075E</gtr:id><gtr:title>Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43f91cd4704ca68d6504ae93c10d3400"><gtr:id>43f91cd4704ca68d6504ae93c10d3400</gtr:id><gtr:otherNames>Kyte DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>qoWXkjAuKGG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>545AECB8-0822-4911-8E2B-08F965859C75</gtr:id><gtr:title>Can we afford to ignore missing data in cost-effectiveness analyses?</gtr:title><gtr:parentPublicationTitle>The European journal of health economics : HEPAC : health economics in prevention and care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8082ef5a08decc6a91548b81bb18a17"><gtr:id>b8082ef5a08decc6a91548b81bb18a17</gtr:id><gtr:otherNames>Marshall A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1618-7598</gtr:issn><gtr:outcomeId>rJV89LZB8yW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35C670E0-95B9-498E-BE74-5F9B63630B90</gtr:id><gtr:title>Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1830b368d2c61589b489ac6b169b8317"><gtr:id>1830b368d2c61589b489ac6b169b8317</gtr:id><gtr:otherNames>Daniels J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>VH7gKCicAes</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>590F4B58-E2CF-4977-B378-34F2326E4D80</gtr:id><gtr:title>Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1681cbb3eb974dd9a78b6cdba6eac10"><gtr:id>d1681cbb3eb974dd9a78b6cdba6eac10</gtr:id><gtr:otherNames>Abba K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>BPSpswSLdaH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A29D6E34-7A9F-46D8-AC53-8F626939D016</gtr:id><gtr:title>Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df58626277b4d2f52fff5ecd94dc5cde"><gtr:id>df58626277b4d2f52fff5ecd94dc5cde</gtr:id><gtr:otherNames>Graves PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>fsV9dkqK3Mk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4F2481-D16B-4EDC-94F1-2E904FFBD9B5</gtr:id><gtr:title>Physiotherapy trials for the 21st century: time to raise the bar?</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d55d63b433e224fc115a6b81f9631a8"><gtr:id>4d55d63b433e224fc115a6b81f9631a8</gtr:id><gtr:otherNames>Rushton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>mNKuREBbPZ6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42738938-97E5-45D7-A507-95015152C17F</gtr:id><gtr:title>Assessing the value of diagnostic tests: a framework for designing and evaluating trials.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf298f8320984a85385a5b029ede647"><gtr:id>daf298f8320984a85385a5b029ede647</gtr:id><gtr:otherNames>Ferrante di Ruffano L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>Q35SEDqH5X1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1814A7BE-24CA-4F2F-AC88-9EF54E01DAC3</gtr:id><gtr:title>Quantifying the impact of between-study heterogeneity in multivariate meta-analyses.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>pfjwHuNVEn3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C5859F4-5922-49D8-93C0-C91E710A6DDB</gtr:id><gtr:title>Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259e8ad0c4fe785b05cbeb1b88ca4393"><gtr:id>259e8ad0c4fe785b05cbeb1b88ca4393</gtr:id><gtr:otherNames>Freemantle N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>WFDQNBuNHA8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>974978D4-AAD0-4CA9-9F97-2965500AEB4A</gtr:id><gtr:title>Case-mix adjusted hospital mortality is a poor proxy for preventable mortality: a modelling study.</gtr:title><gtr:parentPublicationTitle>BMJ quality &amp; safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3831ec5bd89c3962028a071efc9680e2"><gtr:id>3831ec5bd89c3962028a071efc9680e2</gtr:id><gtr:otherNames>Girling AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2044-5415</gtr:issn><gtr:outcomeId>cdrKznn5CiR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09E2B20A-96C0-4AA6-A199-D75B1BCEB57A</gtr:id><gtr:title>Individual participant data meta-analysis of prognostic factor studies: state of the art?</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d762b6e6a56ac4f63c98cc923141e126"><gtr:id>d762b6e6a56ac4f63c98cc923141e126</gtr:id><gtr:otherNames>Abo-Zaid G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>CBSsnYTKmvg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A977A21A-7155-4CBD-8674-DC910918E8BE</gtr:id><gtr:title>Commentary: like it and lump it? Meta-analysis using individual participant data.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>p7CtYxj4WM4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4162D6AC-2708-4B73-B032-FEB5093523EF</gtr:id><gtr:title>Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b75dfb3c06dee46b4a9c493231c0dea"><gtr:id>6b75dfb3c06dee46b4a9c493231c0dea</gtr:id><gtr:otherNames>Cairns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>A49B49E5DD4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D81DEC-1DC8-4093-B757-CE1392D5BFED</gtr:id><gtr:title>Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Statistical applications in genetics and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1877797a282a1a9e27ee928d93ea6dc7"><gtr:id>1877797a282a1a9e27ee928d93ea6dc7</gtr:id><gtr:otherNames>Nyangoma SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1544-6115</gtr:issn><gtr:outcomeId>ed7VPJ4L35p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15DB4D52-2E46-4E4A-BD79-EA213C9D8DBD</gtr:id><gtr:title>Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da567e0749728cb450f3e0581d24435d"><gtr:id>da567e0749728cb450f3e0581d24435d</gtr:id><gtr:otherNames>Sterne JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>LMKq7uGwdyH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B61EB3-34DF-4F87-9E73-00D8DA609285</gtr:id><gtr:title>Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a48c3f37a554cd7b8b57560eb088fef7"><gtr:id>a48c3f37a554cd7b8b57560eb088fef7</gtr:id><gtr:otherNames>Hodgkinson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>BE2Po7cmodf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>316A14D3-D718-42AC-84D4-2358F83FEA46</gtr:id><gtr:title>A statistical framework for quantifying clinical equipoise for individual cases during randomized controlled surgical trials.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42d21ae9070241c7070113fe10179280"><gtr:id>42d21ae9070241c7070113fe10179280</gtr:id><gtr:otherNames>Parsons NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>je5EvzMH2eg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A349A2A8-E048-4D6B-A2DC-F256885927A6</gtr:id><gtr:title>Prognosis Research Strategy (PROGRESS) 3: prognostic model research.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac8b4180281042780bc59e5352f469e"><gtr:id>2ac8b4180281042780bc59e5352f469e</gtr:id><gtr:otherNames>Steyerberg EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>esRy3JCYZsE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>857CD141-1B9B-4D29-9AA4-3731F7FFF11E</gtr:id><gtr:title>The need for increased harmonisation of clinical trials and economic evaluations.</gtr:title><gtr:parentPublicationTitle>Expert review of pharmacoeconomics &amp; outcomes research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/105bb5b723c6b9e55c5a4c2383652ce3"><gtr:id>105bb5b723c6b9e55c5a4c2383652ce3</gtr:id><gtr:otherNames>Gheorghe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-7167</gtr:issn><gtr:outcomeId>5463ad460cea93.03253753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAA67C80-7524-48F8-9897-638FBD7663D4</gtr:id><gtr:title>A refined method for multivariate meta-analysis and meta-regression.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5463b359a58b37.95657218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E41121B3-362D-4FC9-A3AD-757EF543D23B</gtr:id><gtr:title>Designing &amp;quot;Real-World&amp;quot; trials to meet the needs of health policy makers at marketing authorization.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>KKzWHp8ZWKX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D22DCFF-6BC9-4232-9125-8EC775F16ABA</gtr:id><gtr:title>Efficacy of adjuvant chemotherapy after surgery when considered over all cancer types: a synthesis of meta-analyses.</gtr:title><gtr:parentPublicationTitle>Annals of surgical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71d7f40f94356d7678782b2f0f6136dc"><gtr:id>71d7f40f94356d7678782b2f0f6136dc</gtr:id><gtr:otherNames>Bowater RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1068-9265</gtr:issn><gtr:outcomeId>EAPceHpSmUz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7756691-AB7E-4DC9-8EF3-837B8CAB7CBF</gtr:id><gtr:title>Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534da179ef66360293d1ea32201fc21f"><gtr:id>534da179ef66360293d1ea32201fc21f</gtr:id><gtr:otherNames>Mohammed MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>sjSfwipXCFk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77CEDD9C-5B22-45DD-A124-E0CD87A46CDE</gtr:id><gtr:title>Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>585d3224ba3cc3.07703211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B235A513-ABD6-449E-B838-D408274C4C09</gtr:id><gtr:title>What can available randomised controlled trials evaluating monitoring strategies tell us about the design and analysis of future trials?</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683f15bc84737d29fc6068129f342f9e"><gtr:id>683f15bc84737d29fc6068129f342f9e</gtr:id><gtr:otherNames>Dinnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>bg5sF3oJxoQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D05E5DEC-0F83-49B2-A6A0-D0C547D794FE</gtr:id><gtr:title>Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e74e8623ca55eface3c41e51bceb20"><gtr:id>63e74e8623ca55eface3c41e51bceb20</gtr:id><gtr:otherNames>Tudur Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e160e16015c5f7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3D4D9FD-23D1-4C71-83D5-F6F6F5F94D4A</gtr:id><gtr:title>Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da228590f1d8180e3b5c35ebb96f8623"><gtr:id>da228590f1d8180e3b5c35ebb96f8623</gtr:id><gtr:otherNames>Yap C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>CEGxUf9Mm79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AACDDCE-7137-4629-9AA5-2F4AF0E2C444</gtr:id><gtr:title>Using discrete choice experiments to understand preferences for quality of life. Variance-scale heterogeneity matters.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0144e58ef16cefa7e2d015997ecb426"><gtr:id>b0144e58ef16cefa7e2d015997ecb426</gtr:id><gtr:otherNames>Flynn TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>EM9FuTyMBCU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE2532F-FC57-4784-8C44-D82C743B20F5</gtr:id><gtr:title>Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>n65rQMGLbfX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8425109F-6437-4F83-BE65-1D8DE1960B80</gtr:id><gtr:title>A longitudinal assessment of the responsiveness of the ICECAP-A in a randomised controlled trial of a knee pain intervention.</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a02c8ac740b6e5834f02387a5ba7b0"><gtr:id>26a02c8ac740b6e5834f02387a5ba7b0</gtr:id><gtr:otherNames>Keeley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>5675e2d1c195a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>773E133C-7B0D-4FBC-8A4A-B4F2237DE4C0</gtr:id><gtr:title>Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group Phase III Trial in 1363 patients</gtr:title><gtr:parentPublicationTitle>Journal of Thoracic Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06895febd06e7b5da49796796ef86a28"><gtr:id>06895febd06e7b5da49796796ef86a28</gtr:id><gtr:otherNames>Billingham L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>VrxtFUpSfDL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F9F0F3C-9693-446A-BE44-E092BD2FA27A</gtr:id><gtr:title>Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ac1b3503a05e9bac16ce8ad8e66a7b8"><gtr:id>4ac1b3503a05e9bac16ce8ad8e66a7b8</gtr:id><gtr:otherNames>Jolly K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>LabwMqS4ZgT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7E4EC66-5A74-494E-9935-F7B97ACE27FD</gtr:id><gtr:title>A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab95880fea9f9aa85be9e3fa7d3b2db3"><gtr:id>ab95880fea9f9aa85be9e3fa7d3b2db3</gtr:id><gtr:otherNames>Meads C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>rBjJNS1zNV9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7EBEBF0-671D-41E3-BA9B-99EACC91AECC</gtr:id><gtr:title>Secular trends and evaluation of complex interventions: the rising tide phenomenon.</gtr:title><gtr:parentPublicationTitle>BMJ quality &amp; safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/745e53f4056b8e3888d31d91becbb6f4"><gtr:id>745e53f4056b8e3888d31d91becbb6f4</gtr:id><gtr:otherNames>Chen YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-5415</gtr:issn><gtr:outcomeId>585d56e11858d8.80587042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D24F3811-4C08-464A-95C4-2CDD044E62B3</gtr:id><gtr:title>Crossing survival curves: reviewing alternatives to the log-rank test</gtr:title><gtr:parentPublicationTitle>Statistics in Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dabee68563bf84822f0d7aab534bd51"><gtr:id>2dabee68563bf84822f0d7aab534bd51</gtr:id><gtr:otherNames>Bouliotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>sEvnJTxjCRv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1A9C3BE-F127-46D7-89A6-7B4188940BCC</gtr:id><gtr:title>Interpreting composite outcomes in trials.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259e8ad0c4fe785b05cbeb1b88ca4393"><gtr:id>259e8ad0c4fe785b05cbeb1b88ca4393</gtr:id><gtr:otherNames>Freemantle N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_540e15fe15fbda2e5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>371FA2F4-CC80-4054-BAB8-D88BE9F1270A</gtr:id><gtr:title>Exercise therapy for chronic low back pain: protocol for an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8924b478a440d7186591516b0ec9225f"><gtr:id>8924b478a440d7186591516b0ec9225f</gtr:id><gtr:otherNames>Hayden JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>eisvEY9EEN6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9581DA05-2F17-4510-9F02-3EB98E46CBCC</gtr:id><gtr:title>Feasibility of establishing a central repository for the individual participant data from research studies</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2859f4b6c674aac6f0822025826c8b39"><gtr:id>2859f4b6c674aac6f0822025826c8b39</gtr:id><gtr:otherNames>Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>T7nyYMXHe2m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B98AAFD-5172-4B3B-8B5C-44E14AE692E9</gtr:id><gtr:title>Evaluating policy and service interventions: framework to guide selection and interpretation of study end points.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8da950e2f99c70d5b36b5757ab768668"><gtr:id>8da950e2f99c70d5b36b5757ab768668</gtr:id><gtr:otherNames>Lilford RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>iWY2re3QrQT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>664AFB21-063B-445D-A6AF-8976CC48C0BE</gtr:id><gtr:title>Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44c3adfbc893959e98fa93c61897818"><gtr:id>d44c3adfbc893959e98fa93c61897818</gtr:id><gtr:otherNames>Calvert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463ac076966a1.03870500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6A69191-B959-4079-BC2F-3BA2FEE2A609</gtr:id><gtr:title>Evaluating eHealth: how to make evaluation more methodologically robust.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8da950e2f99c70d5b36b5757ab768668"><gtr:id>8da950e2f99c70d5b36b5757ab768668</gtr:id><gtr:otherNames>Lilford RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>EB2wxTDVQDa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9D26483-8C36-42B0-9422-64657ACEB70C</gtr:id><gtr:title>Sample size calculations for stepped wedge and cluster randomised trials: a unified approach.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>585d5774b8c7d3.37511066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64DCE7AD-D02A-4F27-86C6-7387CED7FEFB</gtr:id><gtr:title>Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer.</gtr:title><gtr:parentPublicationTitle>Lung cancer (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c35e0ed16228f62d4678e49013b5bec"><gtr:id>3c35e0ed16228f62d4678e49013b5bec</gtr:id><gtr:otherNames>Malottki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0169-5002</gtr:issn><gtr:outcomeId>56cf4a6c238a67.27448430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>020560B4-E56B-4E42-9F55-CCB209DAA71A</gtr:id><gtr:title>Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38c20e87272a134fc326e2c830c2b292"><gtr:id>38c20e87272a134fc326e2c830c2b292</gtr:id><gtr:otherNames>Sutton AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>WMjZx4jJQHM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2A6966D-9A15-46A2-95D5-1C77114AB2A0</gtr:id><gtr:title>A comparison of short-term and long-term air pollution exposure associations with mortality in two cohorts in Scotland.</gtr:title><gtr:parentPublicationTitle>Environmental health perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d80327f3ee04b7b70bfba32fe9d6cf74"><gtr:id>d80327f3ee04b7b70bfba32fe9d6cf74</gtr:id><gtr:otherNames>Beverland IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6765</gtr:issn><gtr:outcomeId>mPVA6kgVSWG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFDDB439-1D75-43EE-8B72-8E96146077DC</gtr:id><gtr:title>Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III</gtr:title><gtr:parentPublicationTitle>BMJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b79849ed2c64a4c69e82570825464a36"><gtr:id>b79849ed2c64a4c69e82570825464a36</gtr:id><gtr:otherNames>Billingham L</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>mThiVy3Fnng</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4208701-9A31-465F-AA06-2548AEC59124</gtr:id><gtr:title>How to design a meta-analysis in biomarkers</gtr:title><gtr:parentPublicationTitle>JOURNAL OF THORACIC ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3553cbfbd3dbc94450e66fd7485d3e76"><gtr:id>3553cbfbd3dbc94450e66fd7485d3e76</gtr:id><gtr:otherNames>Billingham Lucinda</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1556-0864</gtr:issn><gtr:outcomeId>pSZyq6gDoBS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F41BF60A-E563-44E2-B89A-6D4CBBC6ACD3</gtr:id><gtr:title>Live liver donation, ethics and practitioners: 'I am between the two and if I do not feel comfortable about this situation, I cannot proceed'.</gtr:title><gtr:parentPublicationTitle>Journal of medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1080e71dd312cc712b53353156ba4e96"><gtr:id>1080e71dd312cc712b53353156ba4e96</gtr:id><gtr:otherNames>Thomas EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0306-6800</gtr:issn><gtr:outcomeId>dH9HfkgphFA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65354C2D-76E9-4AB8-8E9A-1DCDACF8B9FE</gtr:id><gtr:title>Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d0d2c3674731421901f51e107db5381"><gtr:id>8d0d2c3674731421901f51e107db5381</gtr:id><gtr:otherNames>Kaambwa B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>pm_16423_23_22738344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2459502-AB0A-4171-889C-B5A12F972948</gtr:id><gtr:title>Laparoscopic uterosacral nerve ablation for alleviating chronic pelvic pain: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1830b368d2c61589b489ac6b169b8317"><gtr:id>1830b368d2c61589b489ac6b169b8317</gtr:id><gtr:otherNames>Daniels J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>KGhudfFqCPU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90FB434E-85BD-4193-9F7E-88F9B09BAFF2</gtr:id><gtr:title>Using e-mail recruitment and an online questionnaire to establish effect size: A worked example.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca60020e3351be5855014abf1dbbf5bd"><gtr:id>ca60020e3351be5855014abf1dbbf5bd</gtr:id><gtr:otherNames>Kirkby HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>tSVDBBVqvx1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59CCA7C9-1426-407E-9ED1-D4903DD1E715</gtr:id><gtr:title>Evaluation and stages of surgical innovations.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c19e41466a812d18006c9ebdbf8ac35"><gtr:id>5c19e41466a812d18006c9ebdbf8ac35</gtr:id><gtr:otherNames>Barkun JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>MkCNCd3J3WW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A574344C-AE67-4F99-8309-CEECE7E18BE2</gtr:id><gtr:title>The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac41f57d8ad418dbe4e222256c23dd5"><gtr:id>3ac41f57d8ad418dbe4e222256c23dd5</gtr:id><gtr:otherNames>Hemming K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55f984984c81583f</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800808</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>